The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Tarsus Pharmaceuticals, Inc(NASDAQ:TARS) 
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase IIb/III for the treatment of blepharitis cau...
Website: http://www.tarsusrx.com
Founded: 2016
Full Time Employees: 18
CEO / Co-Founder: Bobak Azamian
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Tarsus Pharmaceuticals Days Payable Outstanding ttm (DPO)
Tarsus Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Tarsus Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Tarsus Pharmaceuticals Op Cashflow Per Share ttm
Tarsus Pharmaceuticals Free Cashflow Per Share ttm
Tarsus Pharmaceuticals Cash Per Share ttm
Tarsus Pharmaceuticals P/S ratio ttm
Tarsus Pharmaceuticals (GAAP) P/E ratio ttm
Tarsus Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.